Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €2.22 EUR
Change Today 0.00 / 0.00%
Volume 15.0K
B8F On Other Exchanges
As of 6:15 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ulrich Wolfgang Peter Abshagen M.D.

AgeTotal Calculated CompensationThis person is connected to 55 board members in 5 different organizations across 11 different industries.

See Board Relationships


Dr. Ulrich Wolfgang Peter Abshagen, M.D., is the Founder and Managing Partner of Heidelberg Innovation GmbH, Heidelberg Innovation GmbH & Co., and BioScience Venture KG. Dr. Abshagen is the Founder of HI (1996) and has concentrated the years on building HI to become a leading European venture firm. He founded Heidelberg Innovation Gruppe in 1977 and served as its Managing Partner. He has a 20 years track record in building global pharmaceutical businesses. He has ten ...

Read Full Background

Corporate Headquarters*

Hemmelrather Weg 201
Leverkusen, North Rhine-Westphalia 51377


Phone: 49 214 87 63 210
Fax: 49 214 87 63 290

Board Members Memberships*

Non-Executive Director


Bayerische Julius-Maximilians Universität Würzburg
Freie Universität Berlin

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
B8F:GR €2.22 EUR 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOFRONTERA AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at